Expression Pattern of the HMGB1 Gene in Sarcomas of the Dog

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 707-710

  Meyer, Britta ^a   Escobar, Hugo Murua ^a,b   Hauke, Sven ^a   Richter, Andreas ^a   Winkler, Susanne ^a   Rogalla, Piere ^a   Flohr, Aljoscha M ^a   Bullerdiek, Jörn ^a   Nolte, Ingo ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Cisplatin; HMGB1 expression; Osteosarcoma; Semiquantitative RT PCR

Indexed keywords

CISPLATIN; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CONTROLLED STUDY; DOG; DRUG SENSITIZATION; EXCISION REPAIR; GENE; GENE EXPRESSION; GENETIC VARIABILITY; HMGB1 GENE; NONHUMAN; NORTHERN BLOTTING; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, NORTHERN; BONE NEOPLASMS; DOG DISEASES; DOGS; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; LEIOMYOSARCOMA; MALE; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA;

EID: 2442571044     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kartalou M and Essigmann JM: Recognition of cisplatin adducts by cellular proteins. Mutat Res 478: 1-21, 2001.
2. Bustin M, Lehn DA and Landsman D: Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1049: 231-243, 1990.
3. Bustin M and Reeves R: High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54: 35-100, 1996.
4. Jantzen HM, Admon A, Bell SP and Tjian R: Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins. Nature 344: 830-836, 1990.
5. Landsman D and Bustin M: A signature for the HMG-1 box DNA-binding proteins. Bioessays 15: 539-546, 1993.
6. Pil PM and Lippard SJ: Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256: 234-237, 1992.
7. Jung Y and Lippard SJ: Nature of full-length HMGB1 binding to cisplatin-modified DNA. Biochemistry 42: 2664-2671, 2003.
8. Kasparkova J, Delalande O, Stros M, Elizondo-Riojas M-A, Vojtiskova M, Kozelka J and Brabec V: Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein. Biochemistry 42: 1234-1244, 2003.
9. Zamble DB, Mu D, Reardon JT, Sancar A and Lippard SJ: Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35: 10004-10013, 1996.
10. He Q, Liang CH and Lippard SJ: Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci USA 97: 5768-5772, 2000.
11. Chau KY, Lam HY and Lee KL: Estrogen treatment induces elevated expression of HMG1 in MCF-7 cells. Exp Cell Res 241: 269-272, 1998.
12. Borrmann L, Kim I, Schultheiss D, Rogalla P and Bullerdiek J: Regulation of the expression of HMG1, a co-activator of the oestrogen receptor. Anticancer Res 21: 301-305, 2001.
13. Jiang Z, Priat C and Galibert F: Traced orthologous amplified sequence tags (TOASTs) and mammalian comparative maps. Mamm Genome 9: 577-787, 1998.
14. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13, 1983.
15. Wen L, Huang JK, Johnson BH and Reeck GR: A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucleic Acid Res 17: 1197-1214, 1989.
16. Rogalla P, Kazmierczak B, Flohr AM, Hauke S and Bullerdiek J: Back to the roots of a new exon-the molecular archaeology of a SP100 splice variant. Genomics 63: 117-122, 2000.
17. Flohr AM, Rogalla P, Meiboom M, Borrmann L, Krohn M, Thode-Halle B and Bullerdiek J: Variation of HMGB1 expression in breast cancer. Anticancer Res 21: 3881-3885, 2001.
18. Murua Escobar H, Meyer B, Richter A, Becker K, Flohr AM, Bullerdiek J and Nolte I: Molecular characterization of the canine HMGB1. Cytogenet Genome Res 101: 33-38, 2003.
19. Hahn KA, Legendre AM and Talbott JR: The frequency of micronuclei in lymphocytes of dogs with osteosarcomas: a predictive variable for tumor response during cisplatin chemotherapy. Cancer Epidemiol Biomakers Prev 5: 653-656, 1996.
20. Brezniceanu M-L, Völp K, Bösse S, Solbach C, Lichter P, Joos S and Zörnig M: HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast cancer carcinoma. FASEB J 17: 1295-1297, 2003.